Phenotypic characteristics and cyclin-dependent kinase inhibitors repression in hyperplastic epithelial pathology in idiopathic focal segmental glomerulosclerosis

Laboratory Investigation

Volumn 80, Issue 6, 2000, Pages 869-880

  Nagata, Michio ^a   Horita, Shigeru ^b   Shu, Yujing ^a   Shibata, Sawako ^a   Hattori, Motoshi ^b   Ito, Katsumi ^b   Watanabe, Teruo ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYCLIN A; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKERATIN; KI 67 ANTIGEN;

ADOLESCENT; ARTICLE; CELL ADHESION; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REPRESSION; EPITHELIUM HYPERPLASIA; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS EPITHELIUM; HUMAN; HUMAN TISSUE; MALE; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033917136     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780091     Document Type: Article

References (41)

1. Bariety J, Nochy D, Mandet C, Jaquot C, Glotz D, and Meyrier A (1998). Podocytes undergo phenotypic changes and express macrophage associated markers in idiopathic collapsing glomerulopathy. Kidney Int 53:918-925.
2. Barisoni L, Kriz W, Mundel P, and D'Agati V (1999). The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing ideopatic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10:51-61.
3. Cameron JS (1996). The enigma of focal segmental glomerulosclerosis. Kidney Int Suppl 57: S119-S131.
4. Churg J, Habbib R, and White RHR (1970). Pathology of the nephrotic syndrome in children: A report for the International Study of Kidney Disease in Children. Lancet 760:1299-1302.
5. Churg J and Sorbin LH (1982). Focal segmental glomerulosclerosis. In: Churg J, editor. Classification and atlas of glomerular diseases, 2nd ed. Tokyo: IGAKU-SHOIN, 42-43.
6. Combs HL, Shankland SJ, Setzer SV, Hudkins KL, and Alpers CE (1998). Expression of the cyclin kinase inhibitor, p27Kip1, in developing and mature human kidney. Kidney Int 53:892-896.
7. D'Agati V (1994). The many masks of focal segmental glomerulosclerosis. Kidney Int 46:1223-1241.
8. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jaques Y, Hurault de Ligny B, Niaudet P, Charpentier B, and Soulillou JP (1994). Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7-14.
9. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, and Flad HD (1991). Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867-873.
10. Grishman E and Churg J (1975). Focal glomerular sclerosis in nephrotic patients: An electron microscopic study of glomerular podocytes. Kidney Int 7:111-122.
11. Hancock WV and Atkins RC (1983). Monoclonal antibodies to human glomerular cells: A marker for glomerular epithelial cells. Nephron 33:83-90.
12. Hara M, Yamamoto T, Yanagihara T, Takada T, Itoh M, Adachi Y, Yoshizumi A, Kawasaki K, and Kihara I (1995). Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron 69:397-403.
13. Hattori M, Horita S, Yoshioka T, Yamaguchi Y, Kawaguchi H, and Ito K (1997). Mesangial phenotypic changes associated with cellular lesions in primary focal segmental glomerulosclerosis. Am J Kidney Dis 30:632-638.
14. Kip1. J Clin Invest 103:597-604.
15. Kerjaschki D, Poczewski H, Dekan G, Horvat R, Balzar E, Kraft N, and Atkins RC (1986). Identification of a major sialoprotein in the glycocalyx of human visceral epithelial cells. J Clin Invest 78:1142-1149.
16. Kihara I, Tsuchida S, Yaoita E, Yamamoto T, Masanori H, Yanagihara T, and Takada T (1997). Podocyte detachment and epithelial cell retraction in focal segmental glomerulosclerosis with cellular variant. Kidney Int Suppl 63: S171-S176.
17. Kim YG, Alpers CE, Brugarolas J, Johnson RJ, Couser WG, and Shankland SJ (1999). The cyclin kinase inhibitor p21 CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis. Kidney Int 55:2349-2361.
18. Kriz W, Elger M, Nagata M, Kretzler M, Uiker S, Koeppen-Hageman I, Tenchert S, and Lemley K (1994). The role of podocytes in the development of glomerular sclerosis. Kidney Int Suppl 45: S64-S72.
19. Kriz W, Haenel B, Rosener S, and Elger M (1995). Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int 48:1435-1450.
20. Lane EB and Alexander CM (1990). Use of keratin antibodies in tumor diagnosis. Semin Cancer Biol 1:165-179.
21. Kip1 expression in endocrine and other tumors. Am J Pathol 150:401-407.
22. Moll R, Hage C, and Thoenes W (1991). Expression of intermediate filament proteins in fetal and adult human kidney: Modulation of intermediate filament patterns during development and in damaged tissue. Lab Invest 65:74-86.
23. Mundel P, Heid HW, Mundel T, Krueger M, Reiser J, and Kriz W (1997). Synaptopodin: An actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 139: 193-204.
24. Nagata M, Akioka Y, Tsunoda Y, Komatsu Y, Kawaguchi H, Yamaguchi Y, and Ito K (1995a). Macrophages in childhood IgA nephropathy. Kidney Int 48:527-535.
25. Nagata M, Hattori M, Hamano Y, Ito K, Saitou K, and Watanabe T (1998a). Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy. Am J Kidney Dis 32:962-969.
26. Nagata M, Nakayama K, Terada Y, Hoshi S, and Watanabe T (1998b). Cell cycle regulation and differentiation of the human podocyte lineage. Am J Pathol 153:1511-1520.
27. Nagata M, Yamaguchi Y, and Ito K (1993). Loss of mitotic activity and the expression of vimentin in glomerular epithelial cells of developing human kidneys. Anat Embryol (Berl) 187:275-279.
28. Nagata M, Yamaguchi Y, Komatsu Y, and Ito K (1995b). Mitosis and presence of binucleate cells among glomerular podocytes in diseased human kidneys. Nephron 70:68-71.
29. Nitta K, Horita S, Honda K, Uchida K, Watanabe T, Nihei H, and Nagata M (1999). Glomerular expression of cell-cycle-regulatory proteins in human crescentic glomerulonephritis. Virchows Archiv 435: 422-427.
30. Pabst R and Sterzel RB (1983). Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 24:626-631.
31. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, and Massague J (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
32. Pulford KA, Rigney EM, Micklem KJ, Jones M, Stross W, Gatter KC, and Mason DY (1989). KP1: A new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 42:414-421.
33. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F, Fine R, Wood E, Trachtman H (1996). Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883.
34. Schwartz MM and Lewis EJ (1985). Focal segmental glomerular sclerosis: The cellular lesion. Kidney Int 28:968-974.
35. Schwartz MM, Evans J, Bain R, and Korbet SM (1999). Focal segmental glomerulosclerosis: Prognostic implications of the cellular lesion. J Am Soc Nephrol 10:1900-1907.
36. Shankland ST (1997a). Cell-cycle control and renal disease (Review). Kidney Int 52: 294-308.
37. Shankland ST, Floege J, Thomas SE, Nangaku M, Hugo C, Pippin J, Hennke K, Hockenberry DM, Johnson RJ, and Couser WG (1997b). Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 52:404-413.
38. Sharif K, Goyal M, Kershaw D, Kunkel R, and Wiggins R (1998). Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. Exp Nephrol 6:234-244.
39. Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, and Yamanaka N (1996). Apoptosis in progressive crescentic glomerulonephritis. Lab Invest 74:941-51.
40. Valeri AV, Barisoni A, Appel GB, Seigle R, and D'Agati V (1994). Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int 50:1734-1746.
41. Weiss MA, Daquioag E, Margolin G, and Pollak V (1986). Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": A new clinicopathological entity? Am J Kid Dis 7:20-28.